BrandLaunchX Launches AI Platform to Reduce Drug Launch Failures and Accelerate Patient Access to Approved Therapies
New platform addresses the operational gap that causes 80% of therapeutic launches to underperform, delaying patient access to approved medicines LONDON, ENGLAND, UNITED KINGDOM, May 7, 2026 /EINPresswire.com/ -- BrandLaunchX, a UK-based …